![]() |
|||||||||||||||||||||||||
|
|
|
|
|
|
|
|
Contact Us | ||||||||||||||||||
|
|||||||||||||||||||||||||
![]() |
![]() |
The best scientist is open to experience and begins with romance - the idea that anything is possible. Ray Bradbury |
|
Publications Expert Opinion on Therapeutic Patents 2009; 19(12):1727-1757 New patented histone deacetylase inhibitors Haishan Wang & Brian W Dymock AACR 100th Annual Meeting, Denver, April 2009 Pharmacokinetic/Pharmacodynamic (PK/PD) relationships for novel HDAC inhibitors in a mouse xenograft HCT116 tumor model (Abstract No. 2924) Ramesh Jayaraman, Mohammed Khalid Pasha, Pauline Yeo, Kanda Sangthongpitag, Haishan Wang, Hannes Hentze, Veronica Novotny-Diermayr, Jeanette Wood and Kantharaj Ethirajulu AACR 100th Annual Meeting, Denver, April 2009 Novel potent and selective mTOR/PI3K inhibitors that inhibit tumor growth in animal models through efficient and sustained shut down of the PI3K/Akt signaling pathway (Abstract No. 3710) Zahid Bonday, Meredith Williams, Harish Nagaraj, Anders Poulsen, Hannes Hentze, Di Zhong Chen, Stéphanie Blanchard, Stefan Hart, Kee Chuan Goh, Kay Lin Goh, Miah Kiat Goh, Ramesh Jayaraman, Ai Leng Liang, Yung Kiang Loh, Wai Chung Ong, Chang Kai Soh, Mohammed Khalid Pasha, Brian Dymock, Kantharaj Ethirajulu, Jeanette Wood Bioorganic & Medicinal Chemistry Letters 2009; 19(5): 1403 – 1408 N-Hydroxy-1,2-disubsitituted-1H-benzimidazol-5-yl acrylamides as novel histone deacetylase inhibitors: Design, synthesis, SAR studies, and in vivo antitumor activity Haishan Wang, Niefang Yu, Hongyan Song, Dizhong Chen, Yong Zou, Weiping Deng, Pek Ling Lye, Joyce Chang, Melvin Ng, Stéphanie Blanchard, Eric T. Sun, Kanda Sangthongpitag, Xukun Wang, Kee Chuan Goh, Xiaofeng Wu, Hwee Hoon Khng, Lijuan Fang, Siok Kun Goh, Wai Chung Ong, Zahid Bonday, Walter Stünkel, Anders Poulsen, Michael Entzeroth
|